Impairment of autophagy in the central nervous system during lipopolysaccharide-induced inflammatory stress in mice

Molecular Brain

Volumn 7, Issue 1, 2014, Pages

  François, Arnaud ^a   Terro, Faraj ^a,b,c   Quellard, Nathalie ^d   Fernandez, Béatrice ^d   Chassaing, Damien ^a   Janet, Thierry ^a   Bilan, Agnès Rioux ^a   Paccalin, Marc ^a,d   Page, Guylène ^a  

^a UNIVERSITÉ DE POITIERS   (France)

^b UNIVERSITY OF LIMOGES   (France)

^c Service d'Histologie et de Cytogénétique Hôpital de la Mère et de l'Enfant   (France)

^d POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Autophagy; Brain; IL 1 ; Inflammation; Lipopolysaccharide; Mouse

Indexed keywords

BECLIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROTEIN P62; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BIOLOGICAL MARKER; CYTOKINE; TARGET OF RAPAMYCIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BRAIN CORTEX; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; FEMALE; HIPPOCAMPUS; MALE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STRESS; ANIMAL; CENTRAL NERVOUS SYSTEM; INFLAMMATION; METABOLISM; PATHOLOGY; PHYSIOLOGICAL STRESS; ULTRASTRUCTURE;

MUS;

ANIMALS; AUTOPHAGY; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM; CEREBRAL CORTEX; CYTOKINES; FEMALE; HIPPOCAMPUS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MALE; MICE; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; TOR SERINE-THREONINE KINASES;

EID: 84907057534     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/s13041-014-0056-z     Document Type: Article

References (82)

1. mTOR signaling in growth control and disease. M Laplante, DM Sabatini, Cell 2012 149 274 293 10.1016/j.cell.2012.03.017 22500797
2. Amino acid signalling upstream of mTOR. JL Jewell, RC Russell, KL Guan, Nat Rev Mol Cell Biol 2013 14 133 139 10.1038/nrm3522 23361334
3. Complexity of the TOR signaling network. K Inoki, KL Guan, Trends Cell Biol 2006 16 206 212 10.1016/j.tcb.2006.02.002 16516475
4. AMPK phosphorylation of raptor mediates a metabolic checkpoint. DM Gwinn, DB Shackelford, DF Egan, MM Mihaylova, A Mery, DS Vasquez, BE Turk, RJ Shaw, Mol Cell 2008 30 214 226 10.1016/j.molcel.2008.03.003 18439900
5. Complex inhibitory effects of nitric oxide on autophagy. S Sarkar, VI Korolchuk, M Renna, S Imarisio, A Fleming, A Williams, M Garcia-Arencibia, C Rose, S Luo, BR Underwood, G Kroemer, CJ O'Kane, DC Rubinsztein, Mol Cell 2011 43 19 32 10.1016/j.molcel.2011.04.029 21726807
6. Calcium-dependent gene regulation in myocyte hypertrophy and remodeling. RS Williams, P Rosenberg, Cold Spring Harb Symp Quant Biol 2002 67 339 344 10.1101/sqb.2002.67.339 12858558
7. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. A Williams, S Sarkar, P Cuddon, EK Ttofi, S Saiki, FH Siddiqi, L Jahreiss, A Fleming, D Pask, P Goldsmith, CJ O'Kane, RA Floto, DC Rubinsztein, Nat Chem Biol 2008 4 295 305 10.1038/nchembio.79 18391949
8. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Y Wei, S Pattingre, S Sinha, M Bassik, B Levine, Mol Cell 2008 30 678 688 10.1016/j.molcel.2008.06.001 18570871
9. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. E Morselli, MC Maiuri, M Markaki, E Megalou, A Pasparaki, K Palikaras, A Criollo, L Galluzzi, SA Malik, I Vitale, M Michaud, F Madeo, N Tavernarakis, G Kroemer, Cell Death Dis 2010 1 10 10.1038/cddis.2009.8 21364612
10. The life span-prolonging effect of sirtuin-1 is mediated by autophagy. E Morselli, MC Maiuri, M Markaki, E Megalou, A Pasparaki, K Palikaras, A Criollo, L Galluzzi, SA Malik, I Vitale, M Michaud, F Madeo, N Tavernarakis, G Kroemer, Autophagy 2010 6 186 188 10.4161/auto.6.1.10817 20023410
11. Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers. S Sarkar, Biochem Soc Trans 2013 41 1103 1130 10.1042/BST20130134 24059496
12. Life in the balance-a mechanistic view of the crosstalk between autophagy and apoptosis. AD Rubinstein, A Kimchi, J Cell Sci 2012 125 5259 5268 10.1242/jcs.115865 23377657
13. Autophagy and apoptosis dysfunction in neurodegenerative disorders. S Ghavami, S Shojaei, B Yeganeh, SR Ande, JR Jangamreddy, M Mehrpour, J Christoffersson, W Chaabane, AR Moghadam, HH Kashani, M Hashemi, AA Owji, MJ Los, Prog Neurobiol 2014 112 24 49 10.1016/j.pneurobio.2013.10.004 24211851
14. Autophagy as an innate immunity paradigm: expanding the scope and repertoire of pattern recognition receptors. V Deretic, Curr Opin Immunol 2012 24 21 31 10.1016/j.coi.2011.10.006 22118953
15. Autophagy and cellular immune responses. Y Ma, L Galluzzi, L Zitvogel, G Kroemer, Immunity 2013 39 211 227 10.1016/j.immuni.2013.07.017 23973220
16. Role of Autophagy in the Control of Body Metabolism. W Quan, MS Lee, Endocrinol Metab (Seoul) 2013 28 6 11 10.3803/EnM.2013.28.1.6
17. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. N Craddock, ME Hurles, N Cardin, RD Pearson, V Plagnol, S Robson, D Vukcevic, C Barnes, DF Conrad, E Giannoulatou, C Holmes, JL Marchini, K Stirrups, MD Tobin, LV Wain, C Yau, J Aerts, T Ahmad, TD Andrews, H Arbury, A Attwood, A Auton, SG Ball, AJ Balmforth, JC Barrett, I Barroso, A Barton, AJ Bennett, S Bhaskar, K Blaszczyk, et al. Nature 2010 464 713 720 10.1038/nature08979 20360734
18. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. P Brest, P Lapaquette, M Souidi, K Lebrigand, A Cesaro, V Vouret-Craviari, B Mari, P Barbry, JF Mosnier, X Hebuterne, A Harel-Bellan, B Mograbi, A Darfeuille-Michaud, P Hofman, Nat Genet 2011 43 242 245 10.1038/ng.762 21278745
19. Autophagy and Crohn's disease. HT Nguyen, P Lapaquette, MA Bringer, A Darfeuille-Michaud, J Innate Immun 2013 5 434 443 10.1159/000345129 23328432
20. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. WTCC Consortium, Nature 2007 447 661 678 10.1038/nature05911
21. A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap. PS Ramos, LA Criswell, KL Moser, ME Comeau, AH Williams, NM Pajewski, SA Chung, RR Graham, R Zidovetzki, JA Kelly, KM Kaufman, CO Jacob, TJ Vyse, BP Tsao, RP Kimberly, PM Gaffney, ME Alarcon-Riquelme, JB Harley, CD Langefeld, PLoS Genet 2011 7 1002406 10.1371/journal.pgen.1002406 22174698
22. Functional variant in the autophagy-related 5 gene promotor is associated with childhood asthma. LJ Martin, J Gupta, SS Jyothula, M Butsch Kovacic, JM Biagini Myers, TL Patterson, MB Ericksen, H He, AM Gibson, TM Baye, S Amirisetty, AM Tsoras, Y Sha, NT Eissa, GK Hershey, PLoS One 2012 7 33454 10.1371/journal.pone.0033454 22536318
23. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. S Raychaudhuri, BP Thomson, EF Remmers, S Eyre, A Hinks, C Guiducci, JJ Catanese, G Xie, EA Stahl, R Chen, L Alfredsson, CI Amos, KG Ardlie, A Barton, J Bowes, NP Burtt, M Chang, J Coblyn, KH Costenbader, LA Criswell, JB Crusius, J Cui, PL De Jager, B Ding, P Emery, E Flynn, P Harrison, LJ Hocking, TW Huizinga, DL Kastner, et al. Nat Genet 2009 41 1313 1318 10.1038/ng.479 19898481
24. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. T Saitoh, N Fujita, MH Jang, S Uematsu, BG Yang, T Satoh, H Omori, T Noda, N Yamamoto, M Komatsu, K Tanaka, T Kawai, T Tsujimura, O Takeuchi, T Yoshimori, S Akira, Nature 2008 456 264 268 10.1038/nature07383 18849965
25. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J Harris, M Hartman, C Roche, SG Zeng, A O'Shea, FA Sharp, EM Lambe, EM Creagh, DT Golenbock, J Tschopp, H Kornfeld, KA Fitzgerald, EC Lavelle, J Biol Chem 2011 286 9587 9597 10.1074/jbc.M110.202911 21228274
26. Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. CS Shi, K Shenderov, NN Huang, J Kabat, M Abu-Asab, KA Fitzgerald, A Sher, JH Kehrl, Nat Immunol 2012 13 255 263 10.1038/ni.2215 22286270
27. Negative regulation of NLRP3 inflammasome signaling. S Chen, B Sun, Protein Cell 2013 4 251 258 10.1007/s13238-013-2128-8 23519777
28. Crosstalk between autophagy and inflammasomes. JM Yuk, EK Jo, Mol Cells 2013 36 393 399 10.1007/s10059-013-0298-0 24213677
29. Inflammasome activation by altered proteostasis. JN Shin, EA Fattah, A Bhattacharya, S Ko, NT Eissa, J Biol Chem 2013 288 35886 35895 10.1074/jbc.M113.514919 24178293
30. Inhibition of autophagy by TAB2 and TAB3. A Criollo, M Niso-Santano, SA Malik, M Michaud, E Morselli, G Marino, S Lachkar, AV Arkhipenko, F Harper, G Pierron, JC Rain, J Ninomiya-Tsuji, JM Fuentes, S Lavandero, L Galluzzi, MC Maiuri, G Kroemer, EMBO J 2011 30 4908 4920 10.1038/emboj.2011.413 22081109
31. NF-kappaB-mediated induction of autophagy in cardiac ischemia/reperfusion injury. M Zeng, X Wei, Z Wu, W Li, B Li, Y Zhen, J Chen, P Wang, Y Fei, Biochem Biophys Res Commun 2013 436 180 185 10.1016/j.bbrc.2013.05.070 23727575
32. TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. M Pilli, J Arko-Mensah, M Ponpuak, E Roberts, S Master, MA Mandell, N Dupont, W Ornatowski, S Jiang, SB Bradfute, JA Bruun, TE Hansen, T Johansen, V Deretic, Immunity 2012 37 223 234 10.1016/j.immuni.2012.04.015 22921120
33. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. MG Gutierrez, SS Master, SB Singh, GA Taylor, MI Colombo, V Deretic, Cell 2004 119 753 766 10.1016/j.cell.2004.11.038 15607973
34. T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. J Harris, SA De Haro, SS Master, J Keane, EA Roberts, M Delgado, V Deretic, Immunity 2007 27 505 517 10.1016/j.immuni.2007.07.022 17892853
35. Intestinal Epithelium and Autophagy: Partners in Gut Homeostasis. S Randall-Demllo, M Chieppa, R Eri, Front Immunol 2013 4 301 10.3389/fimmu.2013.00301 24137160
36. beta-Cell inflammation in human type 2 diabetes and the role of autophagy. L Marselli, M Bugliani, M Suleiman, F Olimpico, M Masini, M Petrini, U Boggi, F Filipponi, F Syed, P Marchetti, Diabetes Obes Metab 2013 15 Suppl 3 130 136 10.1111/dom.12152 24003929
37. Cathepsin S deficiency results in abnormal accumulation of autophagosomes in macrophages and enhances Ang II-induced cardiac inflammation. L Pan, Y Li, L Jia, Y Qin, G Qi, J Cheng, Y Qi, H Li, J Du, PLoS One 2012 7 35315 10.1371/journal.pone.0035315 22558139
38. The emerging potential of autophagy-based therapies in the treatment of cystic fibrosis lung infections. RD Junkins, C McCormick, TJ Lin, Autophagy 2014 10 538 547 10.4161/auto.27750 24434788
39. Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy. CC Tan, JT Yu, MS Tan, T Jiang, XC Zhu, L Tan, Neurobiol Aging 2014 35 941 957 10.1016/j.neurobiolaging.2013.11.019 24360503
40. Detachment of brain pericytes from the basal lamina is involved in disruption of the blood-brain barrier caused by lipopolysaccharide-induced sepsis in mice. T Nishioku, S Dohgu, F Takata, T Eto, N Ishikawa, KB Kodama, S Nakagawa, A Yamauchi, Y Kataoka, Cell Mol Neurobiol 2009 29 309 316 10.1007/s10571-008-9322-x 18987969
41. Various roles of astrocytes during recovery from repeated exposure to different doses of lipopolysaccharide. Y Bian, X Zhao, M Li, S Zeng, B Zhao, Behav Brain Res 2013 253 253 261 10.1016/j.bbr.2013.07.028 23896049
42. Lipopolysaccharide-induced increases in cytokines in discrete mouse brain regions are detectable using Luminex xMAP technology. SC Datta, MR Opp, J Neurosci Methods 2008 175 119 124 10.1016/j.jneumeth.2008.08.007 18771691
43. Systemic inflammation induces apoptosis with variable vulnerability of different brain regions. A Semmler, T Okulla, M Sastre, L Dumitrescu-Ozimek, MT Heneka, J Chem Neuroanat 2005 30 144 157 10.1016/j.jchemneu.2005.07.003 16122904
44. Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide. N Quan, SK Sundar, JM Weiss, J Neuroimmunol 1994 49 125 134 10.1016/0165-5728(94)90188-0 8294551
45. Inflammation and Alzheimer's disease. H Akiyama, S Barger, S Barnum, B Bradt, J Bauer, GM Cole, NR Cooper, P Eikelenboom, M Emmerling, BL Fiebich, CE Finch, S Frautschy, WS Griffin, H Hampel, M Hull, G Landreth, L Lue, R Mrak, IR Mackenzie, PL McGeer, MK O'Banion, J Pachter, G Pasinetti, C Plata-Salaman, J Rogers, R Rydel, Y Shen, W Streit, R Strohmeyer, I Tooyoma, et al. Neurobiol Aging 2000 21 383 421 10.1016/S0197-4580(00)00124-X 10858586
46. The Beclin 1 network regulates autophagy and apoptosis. R Kang, HJ Zeh, MT Lotze, D Tang, Cell Death Differ 2011 18 571 580 10.1038/cdd.2010.191 21311563
47. Guidelines for the use and interpretation of assays for monitoring autophagy. DJ Klionsky, FC Abdalla, H Abeliovich, RT Abraham, A Acevedo-Arozena, K Adeli, L Agholme, M Agnello, P Agostinis, JA Aguirre-Ghiso, HJ Ahn, O Ait-Mohamed, S Ait-Si-Ali, T Akematsu, S Akira, HM Al-Younes, MA Al-Zeer, ML Albert, RL Albin, J Alegre-Abarrategui, MF Aleo, M Alirezaei, A Almasan, M Almonte-Becerril, A Amano, R Amaravadi, S Amarnath, AO Amer, N Andrieu-Abadie, V Anantharam, et al. Autophagy 2012 8 445 544 10.4161/auto.19496 22966490
48. Functions and regulation of the 70 kDa ribosomal S6 kinases. TR Fenton, IT Gout, Int J Biochem Cell Biol 2011 43 47 59 10.1016/j.biocel.2010.09.018 20932932
49. Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders. ZZ Chong, YC Shang, L Zhang, S Wang, K Maiese, Oxidative Med Cell Longev 2010 3 374 391 10.4161/oxim.3.6.14787
50. Involvement of interleukin-1beta in the autophagic process of microglia: relevance to Alzheimer's disease. A Francois, F Terro, T Janet, AR Bilan, M Paccalin, G Page, J Neuroinflammation 2013 10 151 10.1186/1742-2094-10-151 24330807
51. Systemic administration of lipopolysaccharide induces molecular and morphological alterations in the hippocampus. GA Czapski, B Gajkowska, JB Strosznajder, Brain Res 2010 1356 85 94 10.1016/j.brainres.2010.07.096 20696148
52. Systemic administration of lipopolysaccharide induces cyclooxygenase-2 immunoreactivity in endothelium and increases microglia in the mouse hippocampus. DW Chung, KY Yoo, IK Hwang, DW Kim, JY Chung, CH Lee, JH Choi, SY Choi, HY Youn, IS Lee, MH Won, Cell Mol Neurobiol 2010 30 531 541 10.1007/s10571-009-9477-0 19908141
53. Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. JW Lee, YK Lee, DY Yuk, DY Choi, SB Ban, KW Oh, JT Hong, J Neuroinflammation 2008 5 37 10.1186/1742-2094-5-37 18759972
54. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. L Qin, X Wu, ML Block, Y Liu, GR Breese, JS Hong, DJ Knapp, FT Crews, Glia 2007 55 453 462 10.1002/glia.20467 17203472
55. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. AN Begum, MR Jones, GP Lim, T Morihara, P Kim, DD Heath, CL Rock, MA Pruitt, F Yang, B Hudspeth, S Hu, KF Faull, B Teter, GM Cole, SA Frautschy, J Pharmacol Exp Ther 2008 326 196 208 10.1124/jpet.108.137455 18417733
56. Up-regulation of microglial cathepsin C expression and activity in lipopolysaccharide-induced neuroinflammation. K Fan, X Wu, B Fan, N Li, Y Lin, Y Yao, J Ma, J Neuroinflammation 2012 9 96 10.1186/1742-2094-9-96 22607609
57. Exacerbation of CNS inflammation and neurodegeneration by systemic LPS treatment is independent of circulating IL-1beta and IL-6. CL Murray, DT Skelly, C Cunningham, J Neuroinflammation 2011 8 50 10.1186/1742-2094-8-50 21586125
58. Peripheral lipopolysaccharide administration induces cytokine mRNA expression in the viscera and brain of fever-refractory mice lacking microsomal prostaglandin E synthase-1. C Nilsberth, N Hamzic, M Norell, A Blomqvist, J Neuroendocrinol 2009 21 715 721 10.1111/j.1365-2826.2009.01888.x 19500218
59. Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease. LB Jaeger, S Dohgu, R Sultana, JL Lynch, JB Owen, MA Erickson, GN Shah, TO Price, MA Fleegal-Demotta, DA Butterfield, WA Banks, Brain Behav Immun 2009 23 507 517 10.1016/j.bbi.2009.01.017 19486646
60. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. M Kitazawa, S Oddo, TR Yamasaki, KN Green, FM LaFerla, J Neurosci 2005 25 8843 8853 10.1523/JNEUROSCI.2868-05.2005 16192374
61. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. RA Black, CT Rauch, CJ Kozlosky, JJ Peschon, JL Slack, MF Wolfson, BJ Castner, KL Stocking, P Reddy, S Srinivasan, N Nelson, N Boiani, KA Schooley, M Gerhart, R Davis, JN Fitzner, RS Johnson, RJ Paxton, CJ March, DP Cerretti, Nature 1997 385 729 733 10.1038/385729a0 9034190
62. Pharmacological inhibition of PKR in APPswePS1dE9 mice transiently prevents inflammation at 12 months of age but increases Abeta42 levels in the late stages of the Alzheimer's disease. J Couturier, M Paccalin, C Lafay-Chebassier, S Chalon, I Ingrand, J Pinguet, R Pontcharraud, O Guillard, B Fauconneau, G Page, Curr Alzheimer Res 2012 9 344 360 10.2174/156720512800107582 22272616
63. Cell mediators of inflammation in the Alzheimer disease brain. H Akiyama, T Arai, H Kondo, E Tanno, C Haga, K Ikeda, Alzheimer Dis Assoc Disord 2000 14 Suppl 1 47 S53 10.1097/00002093-200000001-00008 10850730
64. The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review. RA Nixon, AM Cataldo, PM Mathews, Neurochem Res 2000 25 1161 1172 10.1023/A:1007675508413 11059790
65. Peripheral LPS administrations up-regulate Fas and FasL on brain microglial cells: a brain protective or pathogenic event? S Terrazzino, A Bauleo, A Baldan, A Leon, J Neuroimmunol 2002 124 45 53 10.1016/S0165-5728(02)00013-9 11958821
66. Inflammation-induced alteration of astrocyte mitochondrial dynamics requires autophagy for mitochondrial network maintenance. E Motori, J Puyal, N Toni, A Ghanem, C Angeloni, M Malaguti, G Cantelli-Forti, B Berninger, KK Conzelmann, M Gotz, KF Winklhofer, S Hrelia, M Bergami, Cell Metab 2013 18 844 859 10.1016/j.cmet.2013.11.005 24315370
67. Autophagy in immunity and cell-autonomous defense against intracellular microbes. V Deretic, Immunol Rev 2011 240 92 104 10.1111/j.1600-065X.2010.00995.x 21349088
68. Type I interferons induce autophagy in certain human cancer cell lines. H Schmeisser, SB Fey, J Horowitz, ER Fischer, CA Balinsky, K Miyake, J Bekisz, AL Snow, KC Zoon, Autophagy 2013 9 683 696 10.4161/auto.23921 23419269
69. PAMPs and DAMPs: signal 0 s that spur autophagy and immunity. D Tang, R Kang, CB Coyne, HJ Zeh, MT Lotze, Immunol Rev 2012 249 158 175 10.1111/j.1600-065X.2012.01146.x 22889221
70. Osmotic stress inhibits p70/85 S6 kinase through activation of a protein phosphatase. LA Parrott, DJ Templeton, J Biol Chem 1999 274 24731 24736 10.1074/jbc.274.35.24731 10455142
71. TGF-beta inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest. C Petritsch, H Beug, A Balmain, M Oft, Genes Dev 2000 14 3093 3101 10.1101/gad.854200 11124802
72. TNFalpha mediates sepsis-induced impairment of basal and leucine-stimulated signaling via S6K1 and eIF4E in cardiac muscle. CH Lang, AM Pruznak, RA Frost, J Cell Biochem 2005 94 419 431 10.1002/jcb.20311 15534870
73. Hippocampus and cerebral cortex present a different autophagic response after oxygen and glucose deprivation in an ex vivo rat brain slice model. D Perez-Rodriguez, B Anuncibay-Soto, IL Llorente, CC Perez-Garcia, A Fernandez-Lopez, Neuropathol Appl Neurobiol 2014
74. Autophagy in the brain of neonates following hypoxia-ischemia shows sex- and region-specific effects. SN Weis, AP Toniazzo, BP Ander, X Zhan, M Careaga, P Ashwood, AT Wyse, CA Netto, FR Sharp, Neuroscience 2014 256 201 209 10.1016/j.neuroscience.2013.10.046 24184979
75. Dynamic expressions of Beclin 1 and tyrosine hydroxylase in different areas of 6-hydroxydopamine-induced Parkinsonian rats. S Zhang, ZF Xue, LP Huang, RM Fang, YP He, L Li, YQ Fang, Cell Mol Neurobiol 2013 33 973 981 10.1007/s10571-013-9964-1 23868341
76. The blood-brain barrier in psychoneuroimmunology. WA Banks, Neurol Clin 2006 24 413 419 10.1016/j.ncl.2006.03.009 16877115
77. Signaling the brain in systemic inflammation: role of sensory circumventricular organs. J Roth, EM Harre, C Rummel, R Gerstberger, T Hubschle, Front Biosci 2004 9 290 300 10.2741/1241 14766367
78. Immune modulation of learning, memory, neural plasticity and neurogenesis. R Yirmiya, I Goshen, Brain Behav Immun 2011 25 181 213 10.1016/j.bbi.2010.10.015 20970492
79. Caspase 1 activation is protective against hepatocyte cell death by up-regulating beclin 1 protein and mitochondrial autophagy in the setting of redox stress. Q Sun, W Gao, P Loughran, R Shapiro, J Fan, TR Billiar, MJ Scott, J Biol Chem 2013 288 15947 15958 10.1074/jbc.M112.426791 23589298
80. SQSTM1/p62/A170 regulates the severity of Legionella pneumophila pneumonia by modulating inflammasome activity. S Ohtsuka, Y Ishii, M Matsuyama, S Ano, Y Morishima, T Yanagawa, E Warabi, N Hizawa, Eur J Immunol 2014 44 1084 1092 10.1002/eji.201344091 24374573
81. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. S Pankiv, TH Clausen, T Lamark, A Brech, JA Bruun, H Outzen, A Overvatn, G Bjorkoy, T Johansen, J Biol Chem 2007 282 24131 24145 10.1074/jbc.M702824200 17580304
82. Protective effect of dextromethorphan against endotoxic shock in mice. G Li, Y Liu, NS Tzeng, G Cui, ML Block, B Wilson, L Qin, T Wang, B Liu, J Liu, JS Hong, Biochem Pharmacol 2005 69 233 240 10.1016/j.bcp.2004.10.003 15627475